The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
Verifying this paper
8 of 9 steps done · this page updates itself — you can leave and come back
- Registry recordVerified
- Full textFetching the open-access text — a few minutes for a paper we haven’t read before
- Reference listNot fetched yet
- Reference checkNot run yet for this paper
- StatisticsNeeds the full text
- ClaimsNeeds the full text
- Cited sourcesNeeds claims to check
- Self-checkNeeds the full text
- VerificationFindings verified
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
24-OHC has mainly neuroprotective properties, such as preventing tau hyperphosphorylation and Aβ production.
“24-OHC has been shown to have mainly neuroprotective properties, such as preventing tau hyperphosphorylation and Aβ production [66,67].”
From ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis (2022) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
Tau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
DeVos, S. L., Miller, R. L., Schoch, K. M., Holmes, B. B., Kebodeaux, C. S., Wegener, A. J., Chen, G., Shen, T., Tran, H., Nichols, B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0481 · Cited by 516
Flagged first, then by citations
Research works printed but not linked: 43
- Braak, 2015, The preclinical phase of the pathological process underlying sporadic Alzheimer's disease, Brain, 138, 2814, 10.1093/brain/awv236 · DOI · Paper page
- Mattson, 2010, Acetylation unleashes protein demons of dementia, Neuron, 67, 900, 10.1016/j.neuron.2010.09.010 · DOI
- Gamba, 2015, Oxidized cholesterol as the driving force behind the development of Alzheimer's disease, Front Aging Neurosci., 7, 119, 10.3389/fnagi.2015.00119 · DOI · Paper page
- Giudetti, 2016, The role of brain cholesterol and its oxidized products in Alzheimer's disease, Curr. Alzheimer Res., 13, 198, 10.2174/1567205012666150921103426 · DOI
- Björkhem, 2009, Oxysterols and neurodegenerative diseases, Mol. Asp. Med., 30, 171, 10.1016/j.mam.2009.02.001 · DOI · Paper page
- Testa, 2016, Changes in brain oxysterols at different stages of Alzheimer's disease: their involvement in neuroinflammation, Redox Biol., 10, 24, 10.1016/j.redox.2016.09.001 · DOI · Paper page
- Hascalovici, 2009, Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1, J. Neurochem., 110, 1241, 10.1111/j.1471-4159.2009.06213.x · DOI
- Ahonen, 2014, Analysis of oxysterols and vitamin D metabolites in mouse brain and cell line samples by ultra-high-performance liquid chromatography-atmospheric pressure photoionization-mass spectrometry, J. Chromatogr. A., 1364, 214, 10.1016/j.chroma.2014.08.088 · DOI
- Querfurth, 2010, Alzheimer's disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
- Gamba, 2011, Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime, Aging Cell, 10, 403, 10.1111/j.1474-9726.2011.00681.x · DOI
- Gamba, 2014, Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine, Aging Cell, 13, 561, 10.1111/acel.12206 · DOI
- Marwarha, 2013, Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells, PLoS One, 8, e70773, 10.1371/journal.pone.0070773 · DOI
- Urano, 2013, Suppression of amyloid-β production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking, FASEB J., 27, 4305, 10.1096/fj.13-231456 · DOI
- Marwarha, 2010, Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices, J. Alzheimers Dis., 19, 1007, 10.3233/JAD-2010-1298 · DOI
- Prasanthi, 2011, Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus, PLoS One, 6, e26420, 10.1371/journal.pone.0026420 · DOI
- Burlot, 2015, Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology, Hum. Mol. Genet., 24, 5965, 10.1093/hmg/ddv268 · DOI · Paper page
- Herskovits, 2013, Sirtuin deacetylases in neurodegenerative diseases of aging, Cell Res., 23, 746, 10.1038/cr.2013.70 · DOI
- Julien, 2009, Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease, J. Neuropathol. Exp. Neurol., 68, 48, 10.1097/NEN.0b013e3181922348 · DOI
- Bonda, 2011, The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations, Lancet Neurol., 10, 2752, 10.1016/S1474-4422(11)70013-8 · DOI
- Andorfer, 2003, Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms, J. Neurochem., 86, 582, 10.1046/j.1471-4159.2003.01879.x · DOI · Paper page
- Manassero, 2016, Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein, Aging Cell, 15, 914, 10.1111/acel.12500 · DOI
- Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)), Method Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
- Biasi, 2009, Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression, Free Radic. Biol. Med., 47, 1731, 10.1016/j.freeradbiomed.2009.09.020 · DOI
- Gargiulo, 2011, Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions, Free Radic. Biol. Med., 51, 844, 10.1016/j.freeradbiomed.2011.05.030 · DOI
- Vurusaner, 2014, Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation, Free Radic. Biol. Med., 77, 376, 10.1016/j.freeradbiomed.2014.07.026 · DOI
- Vurusaner, 2016, Oxysterols and mechanisms of survival signaling, Mol. Asp. Med., 49, 8, 10.1016/j.mam.2016.02.004 · DOI
- Vurusaner, 2016, Nrf2 antioxidant defense is involved in survival signaling elicited by 27-hydroxycholesterol in human promonocytic cells, Free Radic. Biol. Med., 91, 93, 10.1016/j.freeradbiomed.2015.12.007 · DOI
- Berthier, 2005, 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways, FEBS J., 272, 3093, 10.1111/j.1742-4658.2005.04723.x · DOI
- Riendeau, 2009, Effect of 27-hydroxycholesterol on survival and death of human macrophages and vascular smooth muscle cells, Free Radic. Res., 43, 1019, 10.1080/10715760903040610 · DOI
- Yamanaka, 2011, 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis, J. Biol. Chem., 286, 24666, 10.1074/jbc.M111.236273 · DOI
- Okabe, 2013, Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death, Redox Biol., 2, 28, 10.1016/j.redox.2013.11.007 · DOI
- Testa, 2012, Potentiation of amyloid-β peptide neurotoxicity in human dental-pulp neuron-like cells by the membrane lipid peroxidation product 4-hydroxynonenal, Free Radic. Biol. Med., 53, 10.1016/j.freeradbiomed.2012.08.581 · DOI
- Famer, 2007, Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway, Biochem. Biophys. Res. Commun., 359, 46, 10.1016/j.bbrc.2007.05.033 · DOI
- Prasanthi, 2009, Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells, Mol. Neurodegener., 4, 1, 10.1186/1750-1326-4-1 · DOI
- Paul, 2013, The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors, J. Neurosci., 33, 17290, 10.1523/JNEUROSCI.2619-13.2013 · DOI
- Kim, 2008, Effects of amyloid beta-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols, Biophys. J., 95, 620, 10.1529/biophysj.107.114983 · DOI
- Jang, 2011, 7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways, Neurochem. Int., 58, 52, 10.1016/j.neuint.2010.10.012 · DOI
- Donmez, 2012, The neurobiology of sirtuins and their role in neurodegeneration, Trends Pharmacol. Sci., 33, 494, 10.1016/j.tips.2012.05.007 · DOI
- Julien, 2009, Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease, J. Neuropathol. Exp. Neurol., 68, 48, 10.1097/NEN.0b013e3181922348 · DOI
- Zhang, 2017, The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease, Rev. Neurosci., 28, 861, 10.1515/revneuro-2017-0013 · DOI
- Wang, 2010, Proteolytic processing of tau, Biochem. Soc. Trans., 38, 955, 10.1042/BST0380955 · DOI
- Liu, 2002, Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease, FEBS Lett., 512, 101, 10.1016/S0014-5793(02)02228-7 · DOI · Paper page
- Gough, 2011, Hydrogen peroxide: a Jekyll and Hyde signalling molecule, Cell Death Dis., 2, e213, 10.1038/cddis.2011.96 · DOI
Cited by
Sorted by citations
Varma, V. R., Büşra Lüleci, H., Oommen, A. M., Varma, S., Blackshear, C. T., Griswold, M. E., An, Y., Roberts, J. A., O’Brien, R., Pletnikova, O., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00064-9 · Cited by 153
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
Staurenghi, E., Giannelli, S., Testa, G., Sottero, B., Leonarduzzi, G., & Gamba, P. (2021) · Antioxidants · doi:10.3390/antiox10121890 · Cited by 44
Self-citationStaurenghi, E., Leoni, V., Lo Iacono, M., Sottero, B., Testa, G., Giannelli, S., Leonarduzzi, G., & Gamba, P. (2022) · Antioxidants · doi:10.3390/antiox11112168 · Cited by 24
Self-citation
Metadata
- Authors
- Testa, G., Staurenghi, E., Giannelli, S., Gargiulo, S., Guglielmotto, M., Tabaton, M., Tamagno, E., Gamba, P., & Leonarduzzi, G.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 17
- Pages
- 423-431
- ISSN
- 2213-2317
- Cited by
- 46
- References
- 6
- Language
- en
- Licence
- Funders
- Compagnia di San Paolo (CSTO167048)
- Università degli Studi di Torino (RILO2016)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review